+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Comparative evaluation of antischistosomal drugs



Comparative evaluation of antischistosomal drugs



Meditsinskaya Parazitologiya i Parazitarnye Bolezni 41(5): 608-610



Stibophen, Astiban, Anthiomaline, Ambilhar and Bilharstan (pure tin oxide) were tested on 360 male patients in the Yemen Arab Republic suffering from intestinal and urinary schistosomiasis. The apparent cure rates in urinary schistosomiasis were 90% with Astiban, 83% with stibophen and 80% with Anthiomaline. Ambilhar and Bilharstan were less effective.

(PDF emailed within 1 workday: $29.90)

Accession: 000044821

Download citation: RISBibTeXText



Related references

Comparative value of some currently used antischistosomal drugs. Annals of the New York Academy of Sciences 160(2): 650-655, 1969

Clinical evaluation of antischistosomal drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 61(4): 571-574, 1967

Mutagenic evaluation of antischistosomal drugs and their derivatives in Neurospora crassa. Journal of Toxicology and Environmental Health 1(2): 271-279, 1975

Comparative studies on the pathological findings and mortality in Schistosoma mansoni infected mice after treatment with artesunate and the current antischistosomal drugs. Southeast Asian Journal of Tropical Medicine and Public Health 36(5): 1118-1124, 2006

Evaluation of the mutagenic risk of five antischistosomal drugs to man indices of sces in lymphocytes from treated patients. American Journal of Human Genetics 41(3 SUPPL): A56, 1987

Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni. Journal of Tropical Medicine and Hygiene 87(6): 231-235, 1984

Cytogenetic evaluation and testing of five antischistosomal drugs for mutagenicity and potential teratogenicity or carcinogenicity in Bilharzial patients. American Journal of Human Genetics 57(4 SUPPL ): A113, 1995

Evaluation of the effect of Ro 15-5458 and combined antischistosomal drugs on different strains of Schistosoma mansoni infected albino mice: histopathological and parasitological study. Egyptian Journal of Schistosomiasis and Endemic Infectious Diseases 22: 115-136, 2000

Evaluation of the effect of Ro15-5458 and combined antischistosomal drugs on different strains of Schistosoma mansoni infected albino mice Histopathological and parasitiological study. Virchows Archiv 439(3): 317, 2001

Clinically available antischistosomal drugs. Journal of Toxicology and Environmental Health 1(2): 191-201, 1975

Resistance to antischistosomal drugs State of the art. Acta Parasitologica 45(3): 255, 2000

Advances in research on antischistosomal drugs. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 23(3): 337-339, 2012

Antischistosomal drugs and clinical practice. Human schistosomiasis: 367-404, 1993

Physicochemical properties of antischistosomal drugs. Pharmaceutical Research (New York) 8(10 SUPPL): S131, 1991

Biochemical effects of antischistosomal drugs. , Comparative biochemistry of parasites: 25-32, 1972